[Treatment of osteoporosis: overview].
Nakamura
Toshitaka
T
Department of Orthopedics, School of Medicine, University of Occupational and Environmental Health, Japan.
D015519:Bone Density; D002986:Clinical Trials as Topic; D004164:Diphosphonates / Q000627:therapeutic use; D015914:Estrogen Replacement Therapy; D019317:Evidence-Based Medicine; D005265:Femoral Neck Fractures / Q000209:etiology / Q000517:prevention & control; D015775:Fractures, Stress / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D010024:Osteoporosis / Q000150:complications / Q000378:metabolism; D020849:Raloxifene Hydrochloride / Q000627:therapeutic use; D012307:Risk Factors; D020845:Selective Estrogen Receptor Modulators / Q000627:therapeutic use; D016103:Spinal Fractures / Q000209:etiology / Q000517:prevention & control
D004164:Diphosphonates; D020845:Selective Estrogen Receptor Modulators; D020849:Raloxifene Hydrochloride